Case Studies
AHA to HRSA Re: 340B Civil Monetary Penalty Rule Delay
AHA comments on the Health Resources and Services Administrations interim final rule that would further delay the effective date for the implementation of the Affordable Care Act provision requiring a 340B Drug Pricing Program ceiling price calculation methodology and application of civil monetary penalties for violations of the ceiling price.
Key Resources
Related Resources
Letter/Comment
Letter/Comment
Case Studies